Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in central London

Schauer, A; Kulakov, Elizabeth; Martyn-Simmons, Claire; Bunker, C.B.; Edmonds, E. V. J.

doi:10.1111/ced.14324

Cited by 13 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is imperative in the case of a prolonged COVID‐19 pandemic. Our data are in line with those of a recent UK study 15 showing that the detection rates of melanoma were higher during the lockdown than before the pandemic.…”

Section: Discussionsupporting

confidence: 92%

Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit

Filoni

Fiore

Cappellesso

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

Due to the COVID‐19 crisis, many scheduled medical and surgical activities have been suspended. This interruption to the healthcare system can negatively affect the diagnosis and management of melanoma. Neglecting melanoma throughout the outbreak may be associated with increased rates of mortality, morbidity, and healthcare expenses. We performed a retrospective review of all dermatological and surgical activity performed in our Melanoma Skin Unit between 23 February 2020 and 21 May 2020 and compared these data with those from the same period in 2019. During the lockdown period, we observed a decrease in dermatologic follow‐up (DFU) (−30.2%) and in surgical follow‐up (SFU) (−37%), and no modification of melanoma diagnosis (−3%). Finally, surgical excisions (SE) (+ 31.7%) increased, but sentinel lymph node biopsy (SLNB) (−29%) and lymph node dissections(LND) (−64%) decreased compared to the same period in 2019. Our experience supports the continuation of surgical and diagnostic procedures in patients with melanoma during the COVID‐19 pandemic. Surgical and follow‐up procedures for the diagnosis and treatment of melanoma should not be postponed considering that the pandemic is lasting for an extended period.

show abstract

Section: Discussionsupporting

confidence: 92%

Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit

Filoni

Fiore

Cappellesso

et al. 2021

Dermatologic Therapy

View full text Add to dashboard Cite

show abstract

“…The authors concluded that this outcome highlights the significance of continued skin cancer services during the COVID-19 lockdown. 8 All these data indicate that an obstacle in melanoma diagnosis and treatment can be associated with increased rates of morbidity and mortality. Furthermore, the management of higher-stage diseases requires higher costs.…”

Section: Melanoma Diagnosis and Surgery In The Era Of Covid-19mentioning

confidence: 99%

Melanoma and COVID ‐19: A narrative review focused on treatment

Elmas

Demirbaş

Düzayak

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Melanoma is the most severe form of skin cancer and its incidence has increased over the past few decades. COVID-19 pandemic affected the diagnosis and management of many diseases including melanoma. In this study, we aimed to provide a review focused on the diagnosis and management of melanoma in the era of COVID-19. A comprehensive search was conducted on PubMed, Web of Science, and Google Scholar databases using the keywords "melanoma," "coronavirus," "COVID 19," and "SARS-CoV-2." The relevant guidelines published by the European Society for Medical Oncology and the National Comprehensive Cancer Network were also included. The current guidelines recommend that surgical interventions for new diagnosis of invasive primary melanoma, patients with postoperative complications, wide resection and sentinel lymph node biopsy for newly diagnosed T3-T4 melanoma, and planned surgical procedures for patients in neo-adjuvant trials should be prioritized. Surgical treatment of T3/T4 melanomas should be prioritized over T1/T2 melanomas except for any melanoma in which large clinical residual lesion is visible. Adjuvant therapies can be postponed for up to 12 weeks depending on the local center circumstances. PD-1 inhibitor monotherapy is recommended for patients starting immunologic therapy. Combination immunotherapy is still considered suitable for patients with higher-risk disease. Encorafenib and binimetinib should be prioritized for patients requiring BRAF-targeted therapy due to the lower chance of symptoms mimicking COVID-19 infection.

show abstract

“…In this study, advanced skin cancers were defined as melanomas staged T1b or higher (according to TNM staging) or keratinocyte cancers with high-risk clinical and histopathological features as determined by the clinician. Interestingly, another study reported improved detection of earlier stage during lockdown in London—suggesting the importance of maintained skin referral pathways during pandemics 47 .…”

Section: Introductionmentioning

confidence: 99%

“… When Mohs was performed, 35% reported decrease use of grafts/flaps, 81% reported increased use of dissolvable sutures, and 29% reported increase prescribing of prophylactic antibiotics. Schauer 2020 47 Retrospective study of a UK hospital laboratory database between 27 January 2020 to 22 March 2020; and 23 March 2020 to 18 May 2020 (inclusive) (n=17) Most cases represented early or thin melanomas (7% and 44% for pre- and during lockdown). Malignant melanoma detection rates were higher during lockdown (5.73%).…”

Section: Introductionmentioning

confidence: 99%

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services

Rashid

2021

Dermatologic Clinics

View full text Add to dashboard Cite

: The COVID-19 pandemic has presented a unique set of challenges and lessons to cancer care centers around the world. During this unprecedented time, dermatologists have been pressed to balance early surgical interventions for skin cancer with the risk of COVID-19 transmission. Here, we aim to summarize evidenced-based recommendations for the surgical management and prioritization of three skin cancer categories (cutaneous melanoma, keratinocyte cancer, and Merkel cell carcinoma) during the COVID-19 pandemic.

show abstract

Melanoma defies ‘lockdown’: ongoing detection during Covid‐19 in central London

Cited by 13 publications

References 0 publications

Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit

Management of melanoma patients during COVID‐19 pandemic in an Italian skin unit

Melanoma and COVID ‐19: A narrative review focused on treatment

Effect of the COVID-19 Pandemic on Delayed Skin Cancer Services

Contact Info

Product

Resources

About